Perrigo Company plc Stock TEL AVIV STOCK EXCHANGE
Stocks
PRGO
IE00BGH1M568
Pharmaceuticals
| Market Cap | 1.53B 4.6B 1.34B 1.24B 1.15B 2.18B 146B 2.21B 14.82B 5.77B 71.85B 5.76B 5.64B 249B | P/E 2026 * |
-79.2x | P/E 2027 * | 9.56x |
|---|---|---|---|---|---|
| Enterprise Value | 4.47B 13.4B 3.92B 3.61B 3.35B 6.36B 427B 6.45B 43.2B 16.81B 209B 16.8B 16.43B 726B | EV / Sales 2026 * |
1.1x | EV / Sales 2027 * | 1.06x |
| Free-Float |
99.61% | Yield 2026 * |
10.4% | Yield 2027 * | 10.7% |
Last Transcript: Perrigo Company plc
| 1 day | +0.34% |
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Manzone
CEO | Chief Executive Officer | 63 | 07/06/2026 |
Eduardo Bezerra
DFI | Director of Finance/CFO | 51 | 16/05/2022 |
Matt Winterman
COO | Chief Operating Officer | - | 23/06/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Donal O'Connor
BRD | Director/Board Member | 75 | 01/11/2014 |
Geoffrey Parker
BRD | Director/Board Member | 61 | 07/11/2016 |
Bradley Alford
BRD | Director/Board Member | 70 | 06/02/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.34% | -2.55% | - | - | 1.53B | |
| -1.14% | -2.43% | +53.72% | +159.07% | 1,070B | |
| -1.41% | +0.32% | +66.23% | +60.48% | 624B | |
| -2.42% | +0.18% | +34.59% | +85.62% | 450B | |
| -2.17% | +0.53% | +31.00% | +25.82% | 328B | |
| +0.41% | +0.09% | +38.11% | +39.58% | 292B | |
| +0.11% | -1.33% | +27.96% | +47.10% | 284B | |
| +2.03% | +3.99% | -25.85% | -39.08% | 217B | |
| -2.06% | +1.63% | +22.87% | +64.34% | 198B | |
| -1.26% | +2.60% | +15.98% | +70.00% | 161B | |
| Average | -0.77% | +1.07% | +29.40% | +56.99% | 402.71B | |
| Weighted average by Cap. | -1.09% | +0.77% | +40.04% | +81.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.06B 12.15B 3.55B 3.27B 3.04B 5.77B 387B 5.85B 39.17B 15.24B 190B 15.23B 14.9B 658B | 4.1B 12.28B 3.59B 3.31B 3.07B 5.83B 391B 5.91B 39.58B 15.4B 192B 15.39B 15.05B 665B |
| Net income | -339M -1.02B -297M -273M -254M -482M -32.34B -489M -3.27B -1.27B -15.87B -1.27B -1.25B -55.03B | 161M 484M 141M 130M 121M 229M 15.4B 233M 1.56B 607M 7.56B 606M 593M 26.2B |
| Net Debt | 2.94B 8.81B 2.57B 2.37B 2.2B 4.18B 280B 4.24B 28.38B 11.04B 138B 11.04B 10.79B 477B | 2.83B 8.47B 2.48B 2.28B 2.12B 4.02B 270B 4.08B 27.31B 10.63B 132B 10.62B 10.39B 459B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
